6-65057741-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001142800.2(EYS):​c.2024-14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.221 in 1,402,738 control chromosomes in the GnomAD database, including 37,079 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3422 hom., cov: 31)
Exomes 𝑓: 0.22 ( 33657 hom. )

Consequence

EYS
NM_001142800.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.26

Publications

4 publications found
Variant links:
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
EYS Gene-Disease associations (from GenCC):
  • EYS-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • retinitis pigmentosa 25
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-65057741-G-A is Benign according to our data. Variant chr6-65057741-G-A is described in ClinVar as Benign. ClinVar VariationId is 137269.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.246 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EYSNM_001142800.2 linkc.2024-14C>T intron_variant Intron 12 of 42 ENST00000503581.6 NP_001136272.1 Q5T1H1-1
EYSNM_001292009.2 linkc.2024-14C>T intron_variant Intron 12 of 43 NP_001278938.1 Q5T1H1-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EYSENST00000503581.6 linkc.2024-14C>T intron_variant Intron 12 of 42 5 NM_001142800.2 ENSP00000424243.1 Q5T1H1-1
EYSENST00000370621.7 linkc.2024-14C>T intron_variant Intron 12 of 43 1 ENSP00000359655.3 Q5T1H1-3

Frequencies

GnomAD3 genomes
AF:
0.202
AC:
30444
AN:
150418
Hom.:
3420
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.125
Gnomad AMI
AF:
0.266
Gnomad AMR
AF:
0.152
Gnomad ASJ
AF:
0.246
Gnomad EAS
AF:
0.0507
Gnomad SAS
AF:
0.257
Gnomad FIN
AF:
0.316
Gnomad MID
AF:
0.223
Gnomad NFE
AF:
0.247
Gnomad OTH
AF:
0.215
GnomAD2 exomes
AF:
0.243
AC:
32726
AN:
134792
AF XY:
0.251
show subpopulations
Gnomad AFR exome
AF:
0.137
Gnomad AMR exome
AF:
0.149
Gnomad ASJ exome
AF:
0.270
Gnomad EAS exome
AF:
0.0598
Gnomad FIN exome
AF:
0.316
Gnomad NFE exome
AF:
0.270
Gnomad OTH exome
AF:
0.248
GnomAD4 exome
AF:
0.223
AC:
278888
AN:
1252202
Hom.:
33657
Cov.:
20
AF XY:
0.227
AC XY:
141772
AN XY:
624354
show subpopulations
African (AFR)
AF:
0.118
AC:
3315
AN:
28166
American (AMR)
AF:
0.134
AC:
4257
AN:
31656
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
5986
AN:
23914
East Asian (EAS)
AF:
0.0419
AC:
1465
AN:
34988
South Asian (SAS)
AF:
0.268
AC:
19779
AN:
73752
European-Finnish (FIN)
AF:
0.308
AC:
15081
AN:
49034
Middle Eastern (MID)
AF:
0.217
AC:
1162
AN:
5346
European-Non Finnish (NFE)
AF:
0.228
AC:
216780
AN:
952310
Other (OTH)
AF:
0.209
AC:
11063
AN:
53036
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
10058
20116
30175
40233
50291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6800
13600
20400
27200
34000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.202
AC:
30450
AN:
150536
Hom.:
3422
Cov.:
31
AF XY:
0.206
AC XY:
15123
AN XY:
73446
show subpopulations
African (AFR)
AF:
0.125
AC:
5134
AN:
41048
American (AMR)
AF:
0.152
AC:
2295
AN:
15106
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
850
AN:
3458
East Asian (EAS)
AF:
0.0510
AC:
261
AN:
5120
South Asian (SAS)
AF:
0.258
AC:
1232
AN:
4780
European-Finnish (FIN)
AF:
0.316
AC:
3227
AN:
10218
Middle Eastern (MID)
AF:
0.209
AC:
61
AN:
292
European-Non Finnish (NFE)
AF:
0.247
AC:
16696
AN:
67520
Other (OTH)
AF:
0.217
AC:
453
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1161
2322
3484
4645
5806
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
332
664
996
1328
1660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.234
Hom.:
802
Bravo
AF:
0.181

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 01, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is found in ARRP panel(s). -

not specified Benign:1
Apr 17, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.31
DANN
Benign
0.35
PhyloP100
-3.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45628235; hg19: chr6-65767634; API